1. Home
  2. XPOF vs VNDA Comparison

XPOF vs VNDA Comparison

Compare XPOF & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

HOLD

Current Price

$4.03

Market Cap

205.6M

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$5.25

Market Cap

361.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XPOF
VNDA
Founded
2017
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.6M
361.4M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
XPOF
VNDA
Price
$4.03
$5.25
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$8.13
$14.90
AVG Volume (30 Days)
522.9K
732.7K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
35.24
N/A
EPS
N/A
N/A
Revenue
$11,092,000.00
$216,105,000.00
Revenue This Year
N/A
$21.35
Revenue Next Year
$6.63
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.72
52 Week Low
$3.83
$4.27
52 Week High
$9.25
$9.91

Technical Indicators

Market Signals
Indicator
XPOF
VNDA
Relative Strength Index (RSI) 24.68 46.03
Support Level $3.83 $4.94
Resistance Level $6.15 $5.50
Average True Range (ATR) 0.29 0.19
MACD -0.05 0.01
Stochastic Oscillator 0.28 11.36

Price Performance

Historical Comparison
XPOF
VNDA

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: